A carregar...
Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor
PURPOSE: The paradigm shift in cancer treatment from cytotoxic drugs to tumor targeted therapies poses new challenges, including optimization of dose and schedule based on a biologically effective dose, rather than the historical maximum tolerated dose. Optimal dosing is currently determined using c...
Na minha lista:
| Publicado no: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4646457/ https://ncbi.nlm.nih.gov/pubmed/26571496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0142845 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|